Investigation Overview
September 12, 2016 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Neos Therapeutics Inc (NASDAQ:NEOS) was announced over potential breaches of fiduciary duties by certain officers and directors at Neos Therapeutics. The investigation by a law firm concerns whether certain Neos Therapeutics directors breached their fiduciary duties a...
You must register (for free) or login to view the entire investigation.